FR2415464A1 - Solution embolisante et occlusive injectable, a base de prolamine - Google Patents

Solution embolisante et occlusive injectable, a base de prolamine

Info

Publication number
FR2415464A1
FR2415464A1 FR7902217A FR7902217A FR2415464A1 FR 2415464 A1 FR2415464 A1 FR 2415464A1 FR 7902217 A FR7902217 A FR 7902217A FR 7902217 A FR7902217 A FR 7902217A FR 2415464 A1 FR2415464 A1 FR 2415464A1
Authority
FR
France
Prior art keywords
prolamine
injection
solution
embolising
occlusive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7902217A
Other languages
English (en)
French (fr)
Other versions
FR2415464B1 (US06650917-20031118-M00005.png
Inventor
Herman Dahlke
Hans Muxfeldt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Inc
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of FR2415464A1 publication Critical patent/FR2415464A1/fr
Application granted granted Critical
Publication of FR2415464B1 publication Critical patent/FR2415464B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7902217A 1978-01-30 1979-01-29 Solution embolisante et occlusive injectable, a base de prolamine Granted FR2415464A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2803869A DE2803869C2 (de) 1978-01-30 1978-01-30 Injizierbare Embolisations- und Okklusionslösung

Publications (2)

Publication Number Publication Date
FR2415464A1 true FR2415464A1 (fr) 1979-08-24
FR2415464B1 FR2415464B1 (US06650917-20031118-M00005.png) 1983-07-01

Family

ID=6030689

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7902217A Granted FR2415464A1 (fr) 1978-01-30 1979-01-29 Solution embolisante et occlusive injectable, a base de prolamine

Country Status (8)

Country Link
JP (1) JPS54123281A (US06650917-20031118-M00005.png)
AT (1) AT363599B (US06650917-20031118-M00005.png)
AU (1) AU525929B2 (US06650917-20031118-M00005.png)
CA (1) CA1116088A (US06650917-20031118-M00005.png)
DE (1) DE2803869C2 (US06650917-20031118-M00005.png)
FR (1) FR2415464A1 (US06650917-20031118-M00005.png)
GB (1) GB2014043B (US06650917-20031118-M00005.png)
NL (1) NL191433C (US06650917-20031118-M00005.png)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3374659D1 (en) * 1983-02-03 1988-01-07 Ethicon Inc Paste for hemostasis and for temporary relief of defects in the traumatism of bones
EP0128578A1 (de) * 1983-06-14 1984-12-19 Byk Gulden Lomberg Chemische Fabrik GmbH Ethanolische Kontrastmittelsuspensionen
CA1225585A (en) * 1983-06-30 1987-08-18 Maria T. Litvinova Composition for embolization of blood vessels
US4680171A (en) * 1985-03-15 1987-07-14 William Shell Visualization of a bloodstream circulation with biodegradable microspheres
DE19608278A1 (de) * 1996-02-23 1997-08-28 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie
US6180113B1 (en) 1996-02-23 2001-01-30 Schering Ag Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes
KR970069028A (ko) * 1996-04-01 1997-11-07 김은영 화학색전용 에멀젼의 제조방법
US6333020B1 (en) * 1999-05-13 2001-12-25 Micro Therapeutics, Inc. Methods for treating AVM's using radio active compositions
DE10261694A1 (de) * 2002-12-30 2004-07-15 Brassel, Friedhelm, Prof. Dr.med. Flüssiges Embolisat
ES2640456T3 (es) 2006-09-18 2017-11-03 Fumedica Ag Agente de contraste de rayos X para la angiografía post mortem, experimental y diagnóstica
CH712511B1 (de) * 2006-09-18 2017-11-30 Forim-X Ag C/O Prof Dr Med Richard Dirnhofer Röntgenkontrastmittel für die postmortale, experimentelle und diagnostische Angiographie.
CN107935870A (zh) * 2017-11-09 2018-04-20 华中药业股份有限公司 一种2‑甲氨基‑5‑氯二苯甲酮的合成方法
CN113813392A (zh) * 2021-10-23 2021-12-21 哈尔滨工业大学 一种仿血细胞药物载体的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2052951A1 (US06650917-20031118-M00005.png) * 1969-06-11 1971-04-16 Sterling Drug Inc

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB311382A (en) * 1928-05-10 1930-08-07 H A Metz Lab Inc Improvements in or relating to the manufacture of spinal anaesthetic solutions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2052951A1 (US06650917-20031118-M00005.png) * 1969-06-11 1971-04-16 Sterling Drug Inc

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1978 *

Also Published As

Publication number Publication date
NL191433B (nl) 1995-03-01
NL7900649A (nl) 1979-08-01
ATA65679A (de) 1981-01-15
AU525929B2 (en) 1982-12-09
NL191433C (nl) 1995-07-04
JPS54123281A (en) 1979-09-25
DE2803869C2 (de) 1983-12-29
AT363599B (de) 1981-08-10
FR2415464B1 (US06650917-20031118-M00005.png) 1983-07-01
AU4343079A (en) 1979-08-09
CA1116088A (en) 1982-01-12
JPH0129774B2 (US06650917-20031118-M00005.png) 1989-06-14
DE2803869A1 (de) 1979-08-02
GB2014043B (en) 1982-08-11
GB2014043A (en) 1979-08-22

Similar Documents

Publication Publication Date Title
FR2415464A1 (fr) Solution embolisante et occlusive injectable, a base de prolamine
Turitto et al. Platelet interaction with subendothelium in flowing rabbit blood: effect of blood shear rate
DE69433478T2 (de) Verwendung von stickoxid-addukten zur verhütung von thrombosen auf artifiziellen und vaskulären oberflächen
Essed et al. Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration.
Adams et al. The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo
ATE410119T1 (de) Vorrichtung zur intravaskulären embolisierung
ES2074406T1 (es) Punta de hilo piloto desprendible electroliticamente endovascular.
FR2401662A1 (fr) Compositions adhesives par pression
ES520602A0 (es) Procedimiento para tratar comestibles liquidos que tienen oxigeno disuelto u ocluido.
ES510245A0 (es) "un metodo para obtener una preparacion de insulina".
MX9206336A (es) Metodo para preservacion de un organo ex vivo.
DK155073C (da) Jodholdigt desinfektionsmiddel
Mikhail et al. Observations on the mode of termination and parenchymal distribution of the splenic artery with evidence of splenic lobation and segmentation.
GB1353635A (en) Coating composition for moist surfaces
ES2069915T3 (es) Dicarbonatos y uretanos de los acidos 4,5-dihidroxi- y 4,5,8-trihidroxi-9,10-dihidro-9,10-dioxo-2-antracenocarboxilicos que tienen actividades terapeuticas.
NO891220D0 (no) Middel som inneholder salicylsyre for behandling av lepidose.
FR2773712B1 (fr) Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a
Maegraith Other pathological processes in malaria
KR930012009A (ko) 동맥의 재폐색 방지법
FR2456474A1 (fr) Agent d'entretien pouvant etre pulverise a partir d'un conteneur, et procede pour l'entretien d'instruments medicaux, notamment de dentisterie avec un tel agent
Gottlob et al. The toxic action of alkylcyanoacrylate adhesives on vessels: comparative studies
MX9302924A (es) Agente para tratamiento de cataratas y metodo para su preparacion.
Mullerworth et al. The fate of internal mammary arterial implants and bypass conduits for myocardial revascularization: experimental angiographic, histologic, and ultrastructural observations
Da et al. Changes in the microvasculature after mechanical pressure on the hamster cheek pouch
KIEHN et al. Study of revascularization of blood vessel grafts by means of radioactive phosphorus